Literature DB >> 18027149

Antiangiogenic agents in breast cancer.

John T Salter1, Kathy D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18027149     DOI： 10.1080/07357900701648516

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  7 in total

1.  Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

Authors:  Jacob E Koskimaki; Emmanouil D Karagiannis; Elena V Rosca; Farhad Vesuna; Paul T Winnard; Venu Raman; Zaver M Bhujwalla; Aleksander S Popel
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

2.  From bench to bedside: the growing use of translational research in cancer medicine.

Authors:  Erin M Goldblatt; Wen-Hwa Lee
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

3.  Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI.

Authors:  Xin Li; Wei Huang; Elizabeth A Morris; Luminita A Tudorica; Venkatraman E Seshan; William D Rooney; Ian Tagge; Ya Wang; Jingang Xu; Charles S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-13       Impact factor: 11.205

4.  The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.

Authors:  Wei Huang; Xin Li; Elizabeth A Morris; Luminita A Tudorica; Venkatraman E Seshan; William D Rooney; Ian Tagge; Ya Wang; Jingang Xu; Charles S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

5.  Pre-operative systemic therapy in locally advanced breast cancer: a single institution experience.

Authors:  Em Ibrahim; Am Al-Gahmi; Jm Zekri; Ss Awadalla; Tr Elkhodary; Ee Fawzy; Ya Bahadur; Me Elsayed; A Zeeneldin; Rh Al-Ahmadi; Ah Linjawi
Journal:  Ecancermedicalscience       Date:  2009-10-12

6.  A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.

Authors:  Pedro Correa de Sampaio; David Auslaender; Davia Krubasik; Antonio Virgilio Failla; Jeremy N Skepper; Gillian Murphy; William R English
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

7.  Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.

Authors:  Suk Hyun Choi; Jue Yeon Lee; Jin Sook Suh; Yoon Shin Park; Chong Pyoung Chung; Yoon Jeong Park
Journal:  Int J Nanomedicine       Date:  2016-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.